These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3933645)

  • 1. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.
    Imbasciati E; Gusmano R; Edefonti A; Zucchelli P; Pozzi C; Grassi C; Della Volpe M; Perfumo F; Petrone P; Picca M
    Br Med J (Clin Res Ed); 1985 Nov; 291(6505):1305-8. PubMed ID: 3933645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome.
    Yeung CK; Wong KL; Ng WL
    Aust N Z J Med; 1983 Aug; 13(4):349-51. PubMed ID: 6580858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
    Fukudome K; Fujimoto S; Sato Y; Kitamura K
    Nephrology (Carlton); 2012 Mar; 17(3):263-8. PubMed ID: 22117558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome.
    Li X; Liu Z; Wang L; Wang R; Ding G; Shi W; Fu P; He Y; Cheng G; Wu S; Chen B; Du J; Ye Z; Tao Y; Huo B; Li H; Chen J
    J Am Soc Nephrol; 2017 Apr; 28(4):1286-1295. PubMed ID: 27807213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of childhood nephrotic syndrome.
    Mendoza SA; Tune BM
    J Am Soc Nephrol; 1992 Oct; 3(4):889-94. PubMed ID: 1450365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).
    Rémy P; Audard V; Natella PA; Pelle G; Dussol B; Leray-Moragues H; Vigneau C; Bouachi K; Dantal J; Vrigneaud L; Karras A; Pourcine F; Gatault P; Grimbert P; Ait Sahlia N; Moktefi A; Daugas E; Rigothier C; Bastuji-Garin S; Sahali D;
    Kidney Int; 2018 Dec; 94(6):1217-1226. PubMed ID: 30385039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse methylprednisolone therapy in severe idiopathic childhood nephrotic syndrome.
    Murnaghan K; Vasmant D; Bensman A
    Acta Paediatr Scand; 1984 Nov; 73(6):733-9. PubMed ID: 6524363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily single-dose and daily reduced-dose prednisone therapy for children with the nephrotic syndrome.
    Warshaw BL; Hymes LC
    Pediatrics; 1989 May; 83(5):694-9. PubMed ID: 2717285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial.
    Li Y; Fu R; Gao J; Wang L; Duan Z; Tian L; Ge H; Ma X; Zhang Y; Li K; Xu P; Tian X; Chen Z
    Sci Rep; 2022 Jan; 12(1):255. PubMed ID: 34996948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis.
    Garin EH; Sleasman JW; Richard GA; Iravani AA; Fennell RS
    Eur J Pediatr; 1986 Oct; 145(5):380-3. PubMed ID: 3792382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
    Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
    Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
    N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome.
    Matsumoto H; Nakao T; Okada T; Nagaoka Y; Takeguchi F; Tomaru R; Iwasawa H
    Intern Med; 2004 Aug; 43(8):668-73. PubMed ID: 15468963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease.
    Ozeki T; Katsuno T; Hayashi H; Kato S; Yasuda Y; Ando M; Tsuboi N; Hagiwara D; Arima H; Maruyama S
    Am J Nephrol; 2019; 49(1):54-63. PubMed ID: 30557879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up.
    Tune BM; Kirpekar R; Sibley RK; Reznik VM; Griswold WR; Mendoza SA
    Clin Nephrol; 1995 Feb; 43(2):84-8. PubMed ID: 7736683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
    N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
    Peña A; Bravo J; Melgosa M; Fernandez C; Meseguer C; Espinosa L; Alonso A; Picazo ML; Navarro M
    Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions in adults: a randomized controlled trial.
    Chen J; Li R; Guo H; Zhu T; Xu Y; Yao C; Liu H
    Nephrol Dial Transplant; 2024 Sep; ():. PubMed ID: 39333014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.